Search Results - "Dolatkhah, Mitra"
-
1
Renewed interests in carbonic anhydrase IX in relevance to breast cancer treatment
Published in Bioimpacts (01-01-2019)“…The highly proliferating cancerous cells can form permissive accommodating milieu – the so-called tumor microenvironment (TME). During the initiation of solid…”
Get full text
Journal Article -
2
Graphene-based multifunctional nanosystems for simultaneous detection and treatment of breast cancer
Published in Colloids and surfaces, B, Biointerfaces (01-09-2020)“…[Display omitted] •Tumor microenvironment (TME) acts as a barrier to cancer drug delivery and targeting.•Graphene-based nanosystems show great potential for…”
Get full text
Journal Article -
3
Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines
Published in Life sciences (1973) (15-04-2021)“…Breast cancer (BC) is one of the prevalent cancers among women. Generally, the treatment of BC is mostly based on several prominent strategies, including…”
Get full text
Journal Article -
4
Folate receptor-mediated delivery of 1-MDT-loaded mesoporous silica magnetic nanoparticles to target breast cancer cells
Published in Nanomedicine (London, England) (01-10-2021)“…The efficiency of mesoporous silica magnetic nanoparticles (MSMNP) as a targeted drug-delivery system was investigated. The superparamagnetic iron oxide…”
Get full text
Journal Article -
5
Stimuli-responsive graphene oxide and methotrexate-loaded magnetic nanoparticles for breast cancer-targeted therapy
Published in Nanomedicine (London, England) (01-10-2021)“…Nanocomposites of graphene oxide (GO) loaded with PEGylated superparamagnetic iron oxide nanoparticles and grafted with methotrexate and stimuli-responsive…”
Get full text
Journal Article -
6
Targeted combined therapy in 2D and 3D cultured MCF-7 cells using metformin and erlotinib-loaded mesoporous silica magnetic nanoparticles
Published in Journal of microencapsulation (17-11-2021)“…This research aims to develop potential therapeutic nanostructures (NSs) encapsulating metformin (MET) and erlotinib (ER) for combinational therapy in breast…”
Get full text
Journal Article -
7
Preventive Effect of Atorvastatin (80 mg) on Contrast-Induced Nephropathy After Angiography in High-Risk Patients: Double-Blind Randomized Clinical Trial
Published in Nephro-urology monthly (01-05-2016)“…Contrast-induced nephropathy (CIN) is one of the most important complications of angiography in patients with chronic kidney disease (CKD) or diabetes…”
Get full text
Journal Article